Company news
Scholar Rock Holding Corporation (NASDAQ:SRRK) news
Scholar Rock Holding Corporation news releases on 6ix. Latest, Jan 27, 2021: Scholar Rock Presents Preclinical Data for SRK-181 at the TGFβ…
Press releases — page 4
Scholar Rock Presents Preclinical Data for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit
January 26, 2021
Scholar Rock Provides Corporate Update and Highlights Priorities for 2021
January 10, 2021
Scholar Rock to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 3, 2021
Scholar Rock Reports Third Quarter 2020 Financial Results and Highlights Business Progress
November 8, 2020
Scholar Rock Announces Closing of Public Offering of Common Stock and Prefunded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
November 1, 2020
Scholar Rock Announces Pricing of Public Offering of Common Stock and Prefunded Warrants
October 27, 2020
Scholar Rock Announces Positive Proof-of-Concept Data from TOPAZ Phase 2 Trial Interim Analysis of SRK-015 in Patients with Type 2 and Type 3 Spinal Muscular Atrophy
October 26, 2020
Scholar Rock Secures $50 million Debt Facility with Silicon Valley Bank and Oxford Finance
October 18, 2020
Scholar Rock Presents Data for SRK-015 at the World Muscle Society 2020 Virtual Congress
September 29, 2020
Scholar Rock Announces First Patient Dosed in Part A2 of DRAGON Phase 1 Proof-of-Concept Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy
September 8, 2020
Scholar Rock Announces Issuance of U.S. Patent Providing Composition of Matter Protection for SRK-015
August 26, 2020
Scholar Rock Announces that SRK-015 has Received Rare Pediatric Disease Designation from U.S. FDA for the Treatment of Spinal Muscular Atrophy
August 12, 2020
Scholar Rock Reports Second Quarter 2020 Financial Results and Highlights Business Progress
August 6, 2020
Scholar Rock to Present at the 2020 Wedbush PacGrow Healthcare Conference
August 4, 2020
Scholar Rock to Announce Second Quarter 2020 Financial Results and Introduce Newest Members of Management August 7, 2020
August 2, 2020
Scholar Rock Appoints Edward (Ted) Myles as Chief Financial Officer and Head of Business Operations
July 15, 2020
Scholar Rock Appoints Tony Kingsley as President and CEO
July 13, 2020
Scholar Rock to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
June 15, 2020
Scholar Rock Presents Clinical and Preclinical Data for SRK-015 at the 2020 Virtual Cure SMA Research and Clinical Care Meeting
June 11, 2020
Scholar Rock to Present at the Jefferies Virtual Global Healthcare Conference
May 26, 2020
Scholar Rock Appoints Tony Kingsley to Its Board of Directors
May 20, 2020
Scholar Rock Presents Baseline Demographics Data from the SRK-015 TOPAZ Trial at the American Academy of Neurology Conference
May 17, 2020
Scholar Rock Reports First Quarter 2020 Financial Results and Highlights Business Progress
May 6, 2020
Scholar Rock Announces Initiation of Patient Dosing in Phase 1 Proof-of-Concept Immuno-Oncology Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy
May 4, 2020
Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Antibodies that Modulate TGFβ Activation
April 8, 2020
Scholar Rock Reports Full Year 2019 Financial Results and Highlights Business Progress
March 11, 2020
Scholar Rock Achieves First Milestone in Strategic Fibrosis Collaboration with Gilead Sciences
January 8, 2020
Scholar Rock Reports Preliminary Pharmacokinetic and Pharmacodynamic Data from TOPAZ Phase 2 Trial of SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy
November 18, 2019
Scholar Rock Reports Third Quarter 2019 Financial Results and Highlights Business Progress
November 11, 2019